Enzyme link to diabetes treatment

According to recent research in London, scientists have found that the structure of an enzyme could have a clear role in understanding the mutations responsible for causing diabetes and other diseases, such as cancer .
This particular enzymen, known as p300/CBP, could therefore have potential usage to design and develop drugs to treat diabetes, HIV, heart disease and cancer The study was reportedly led by an expert at the John Hopkins University School of Medicine in Baltimore .
Using complex research procedures the research team found that the enzymen, which has been identified for over a decade, could be very useful in the future. The function of the enzyme apparently explains why mutations could lead to disease.
The fresh research appeared the most recent issue of the journal, Nature.